(4-(Pyridin-3-yl)phenyl)boronic acid, 95.0%, 100g

Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-bis(acetyloxy)-5-(chloromethyl)-, 1mg

Sodium hydroxide solution, ROTIPURAN® min. 32%, pa, 2.5 l, plastic packaging.

Dimethyl Pimelimidate Dihydrochloride [Cross-linking Agent for Peptides Research]>98.0%(T)5g

4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxamide, 98%, 5g

3-Bromo-a-methylbenzyl alcohol, 97.0%, 1g

4-Chloro-7-methyl-1H-indole, 95.0%, 1g

2,5,8,11,14,17,20-Heptaoxadocosan-22-amine, 97%, 1g

2,3-Dihydropyrazolo[5,1-b][1,3]oxazol-6-ylmethanol, 1g

N-(5-Amino-2-methylphenyl)-4-methylbenzamide, 95.0%, 1g

1-(Pyridin-3-ylmethyl)piperazine trihydrochloride, 95.0%, 500mg

ethyl 3-amino-6-methylthieno[2,3-b]pyridine-2-carboxylate, 95.0%, 1g

Volumetric flasks class A opaque, 25 ml, 10/19, 2 Piece(s)